Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.
One example: Paragraph: "Although the story didn't cite the cost of appendectomy emergency or urgent surgery and we wish it had, we nonetheless will give it a satisfactory score because it at least cited what the editorial writer wrote, ""A secondary benefit is the savings to the hospital generated by minimizing staff and anesthesiologist presence late in the evening and during the wee hours of the morning."" As with our harms score above, although the story didn't give absolute numbers, in this case we think it was sufficient for it to report that ""The scientists found no significant difference among the groups in the patients' condition 30 days after surgery or in the length of their operation or hospital stay."" Although the story didn't give absolute numbers, in this case we think it was sufficient for it to report that ""The scientists found no significant difference among the groups in the patients' condition 30 days after surgery or in the length of their operation or hospital stay."" Despite running less than 300 words, this story did an adequate job in explaining the quality of the evidence, including pointing out limitations. No disease-mongering here. The story meets the bare minimum requirement for this criterion in that it at least cited what an editorial stated. The focus of the story was on a study comparing emergency appendectomy with surgery done up to 12 hours later or beyond. This is the whole focus of the story and one we applaud when it begins: ""Appendectomy is the most common emergency surgery in the world, but it doesn't have to be."" There were no claims made about the novelty of this research, and we may have wished for a bit more context on this. Nonetheless, the potential for guiding future care decisions was made clear. Not applicable. Given that the story only pulled excerpts from the journal article and the accompanying editorial, and didn't include any fresh quotes from interviews, we can't be sure of the extent to which it may have been influenced by a news release.". Claim: Some appendicitis cases may not require 'emergency' surgery
Solution is here: We really don't understand why only a handful of mainstream news organizations reported this story. (At least in what we found.) The most common emergency surgery in the world. Rushing to emergency surgery may not carry any benefit. Waiting a few hours may be safer and less expensive. Why is that not a story? We applaud USA Today for finding time and space and clearly it didn't need to free up much space to do a good job telling the story. The story explains that as many as 300,0 appendectomies are done each year in the US. That figure alone explains why this is an important study to report.
Explanation: The output is an analysis of the claim while considering the paragraph as a reference. The output highlights the key features presented in the paragraph and explains the claim accordingly.

Now, solve this: Paragraph: The dwindling stockpile of crucial medications follows the abrupt departure of the Global Fund to Fight AIDS, Tuberculosis and Malaria, an international aid organization whose grants to North Korea supported the treatment of 120,000 TB patients last year. Its support officially ended in June despite an outcry among health officials in North Korea and in the international community that it could spark a major epidemic. Neurosurgeon Kee Park, of the Program in Global Surgery and Social Change at Harvard Medical School, said in an email to The Associated Press that the situation is extremely dire and likely to get dramatically worse in the years ahead if it is not properly dealt with. The U.S.-based nonprofit Eugene Bell Foundation, which works on the ground treating tuberculosis in North Korea, said Friday that the crisis is being compounded by U.S.-led sanctions over Pyongyang's nuclear weapons and missile program. North Korea has one of the world's highest rates of tuberculosis, a highly infectious disease that, while treatable, globally causes more than 1 million deaths each year. According to the World Health Organization, about 107,000 cases of tuberculosis were reported in North Korea in 2017. Making matters worse, North Korea has estimated that 6-7 percent of its tuberculosis population has the drug-resistant variety, known as MDR-TB, which is far more difficult and costly to cure. "As a result of the loss of the Global Fund grants for the DPRK, we expect a 50-75 percent reduction in treatment capacity for non-MDR-TB patients," Park said. "Consequently, our model predicts between 155,000 to 210,000 more people will die from TB-related causes within five years. To be clear, these are new deaths that are expected on top of the current mortality rates. We have assumed that the treatment of MDR-TB will continue at current levels." Drug-resistant tuberculosis generally results from patients not taking the proper amount or combination of medications to completely cure them of the disease, or by coming into contact with someone who has been infected with it already. It is often found among populations that have had some exposure to TB medications, such as cities or other places with populations that are relatively more affluent or at least affluent enough to have paid for some form of TB medication already. Pyongyang, the North Korean capital, is believed to have a particularly high incidence of the drug-resistant TB strain. Global Fund announced in February that it was ending its grants to North Korea, effectively ending the largest outside public health assistance program ever for the North, because of a lack of transparency and difficult operating conditions. It has said its stockpile would last for a year, which is longer than the average 6- to 9-month course of treatment for a TB patient. But the concern is over what will happen after that, how any new cases can be treated if no one else steps in to fill the gap and whether the limited pool of medications would be "rationed" in an ill-advised effort to spread out what medications are left. "Time is ticking," Park said. "I have heard from people who have been inside recently that the rationing has already started." The problem is especially acute because North Korea has a fragile public health system that could easily be overwhelmed by a large outbreak, sending North Koreans streaming across the country's border with China, making the epidemic a bigger, regional issue. Concerns over such a calamity prompted the North to essentially close its borders during the Ebola scare in 2015 and during the SARS outbreak in 2003 in China, though neither seemed to present much of a threat to the isolated North. Stephen Linton, chairman of the Eugene Bell Foundation, told reporters in Seoul that South Korea lacks the sense of urgency to help groups like his gain sanctions exemptions so that they can deliver supplies to treat patients in North Korea. He likened the problem to having the house next door on fire, and said North Korea's tuberculosis problem could potentially have health consequences for South Korea. Linton said he believes Global Fund's decision was at least partially connected to sanctions-related pressure. The U.S. government, which pledged $1.4 billion this year, is one of the biggest donors to Global Fund. He noted that it has also gotten harder for American aid workers to get permission to travel to the North since President Donald Trump announced his travel ban for U.S. citizens more than a year ago. Choi Seemoon, a Eugene Bell director, said that while Eugene Bell and Global Fund have provided MDR-TB medications to about 2,000 patients this year, that's less than 30 percent of the estimated 8,000 North Koreans with the condition. Global Fund's stock of regular tuberculosis medicine will run out in early 2020, she warned, while its stock of MDR-TB medicine can only cover patients registered by the autumn of this year. "There needs to be a quick purchase of medicine and supplies to overcome the void left by Global Fund," Choi said. "Whether the issue is resolved through inter-Korean talks or through international bodies and non-governmental channels, there should be a quick delivery of tuberculosis medicine to North Korea regardless of what channel it takes." ___ Talmadge is the AP's Pyongyang bureau chief. He contributed to this report from Tokyo. Follow him on Twitter and Instagram: @EricTalmadge. Claim: North Korea running low on TB meds, experts fear epidemic.
Solution:
The withdrawal of a major international aid organization threatens to leave tens of thousands of tuberculosis patients in North Korea without the medication they need and could spiral into a severe crisis if it is not addressed soon, according to health experts familiar with the situation in the North.